AZ’s NDA filing anticipated based on positive data from interim analysis

First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease

Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer

What is Decentralized clinical trials?:Benefits and challenges of implementing DCT

FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US